What the Dovato TV commercial - Luciano is about.
The Dovato TV Spot, 'Luciano' is a compelling and emotional advertisement that tells the story of a man named Luciano who has been living with HIV for 17 years. The spot showcases Luciano's journey and how he has managed to live a fulfilling life while being HIV positive.
The ad begins with a shot of Luciano sitting outside in his backyard, reflecting on his life. He narrates his story and how he found out he was HIV positive. He talks about how he felt lonely and depressed, but eventually found hope through treatment. As he speaks, the scenes cut to Luciano playing with his children, working on art, and living his life to the fullest.
The ad focuses on promoting Dovato, a medication that helps treat HIV. Luciano talks about how, with the help of Dovato, he was able to achieve viral suppression. The medication has helped him maintain a healthy lifestyle and allowed him to continue pursuing his passions.
The TV spot is very moving and relatable, highlighting the importance of HIV treatment and the positive impact it can have on one's life. The ad is well-crafted, combining powerful imagery with a personal story to create an impactful message. It educates and raises awareness about HIV treatment, showing that it is possible to live a full and fulfilling life while being HIV positive.
Dovato TV commercial - Luciano produced for
Dovato
was first shown on television on June 28, 2021.
Frequently Asked Questions about dovato tv spot, 'luciano'
The main actor in the Dovato commercial is Chris Mears. He is a British Olympic diver who won a gold medal in the synchronized 3-meter springboard event at the 2016 Rio Olympics. Mears is also an HIV advocate, having publicly spoken about his own experience with the virus.
DOVATO Dosing
- ONCE A DAY.
- TAKEN ANY TIME OF DAY.
- WITH OR WITHOUT FOOD.
- BOOSTER FREE.
In the switch market for patients who are already virologically suppressed, Dovato already boasts more than 10% share in the U.S., though Waterhouse acknowledged there was some off-label use before the official August FDA nod in that indication.
DOVATO is a complete prescription regimen to treat HIV-1 in adults who have not received HIV-1 medicines in the past or to replace their current HIV-1 medicines when their doctor determines they meet certain requirements.
What is Dovato and what is it used for? Dovato is a medicine for treating infection with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). It is used to treat adults and adolescents over 12 years old who weigh at least 40 kg.
ViiV Healthcare LLC is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV.
Dovato has an average rating of 6.1 out of 10 from a total of 40 reviews on Drugs.com. 49% of reviewers reported a positive experience, while 38% reported a negative experience.
How does Dovato work? The two active substances in Dovato, dolutegravir and lamivudine, block the activity of enzymes that the virus uses to make new copies of itself in the body.
Dovato is a once-daily, single-pill, 2-drug regimen (2DR) for treatment-naïve HIV infection that combines dolutegravir, an integrase inhibitor (INI), with the nucleoside reverse transcriptase inhibitor (NRTI) lamivudine.
How do I take Dovato? You should take Dovato once a day. Dovato can be taken with or without food. HIV treatment works best if you take it every day, ideally at the same time each day.
Official answer. Dovato (a 2-drug regimen) has been shown to be as effective as 3- or 4-drug HIV treatments in helping you to reach or stay at undetectable levels (less than 50 copies HIV per mL). Dovato is a single tablet that contains two HIV medicines. It is taken once daily (with or without food).
Dovato was first approved by the FDA in April 2019 as a complete regimen for the treatment of HIV-1 infection in adults with no ARV treatment history and with no known resistance to the individual components of Dovato.